Now showing items 1-8 of 8
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
(ELSEVIER SCIENCE INC, 2009)
The 4th World Symposium on Pulmonary Hypertension was the first international meeting to focus not only on pulmonary arterial hypertension (PAH) but also on the so-called non-PAH forms of pulmonary hypertension (PH). The ...
Metabolic Connection between Incretins and Pulmonary Hypertension
(Biomed Central Ltd, 2015-07-01)
Studies show that at least half the adult population is overweight in most countries. Recent case reports have shown the important metabolic potential of the pathophysiology of PAH. Many cases of PAH, etiologically classified ...
Survival of patients with pulmonary arterial hypertension after the advent of specific pulmonary vasodilator therapies
(Soc. Médica Santiago, 2016)
Background: Pulmonary arterial hypertension (PAH) is a rare and progressive disease. Long-term survival remains poor despite of advances in specific vasodilator therapy. Aim: To describe the survival rate in a cohort of ...
Systemic oxidative stress and endothelial dysfunction is associated with an attenuated acute vascular response to inhaled prostanoid in pulmonary artery hypertension patients
Background: Systemic endothelial dysfunction and increased oxidative stress have been observed in pulmonary arterial hypertension (PAH). We evaluate whether oxidative stress and endothelial dysfunction are associated with ...
Hipertensión arterial pulmonar: el entrenamiento físico como complemento de la terapia farmacológica
(Sociedad Médica de Santiago, 2018)
Cardiopulmonary rehabilitation is a promising therapy for Pulmonary arterial hypertension (PAH) whose survival does not exceed 65% at five years. We performed a literature search about rehabilitation on PAH in MEDLINE, ...
Inhibition of mitochondrial fission prevents hypoxia-induced metabolic shift and cellular proliferation of pulmonary arterial smooth muscle cells
Chronic hypoxia exacerbates proliferation of pulmonary arterial smooth muscle cells (PASMC), thereby reducing the lumen of pulmonary arteries. This leads to poor blood oxygenation and cardiac work overload, which are the ...
Esplenectomia e outros fatores de risco para hipertensão pulmonar em pacientes com esquistossomose hepatoesplênica
(Universidade Federal de Pernambuco, 2015)
Papel de receptores P2Y2 y/o P2Y4 en venas intrapulmonares pequeñas en un modelo de hipertensión arterial pulmonar
(Universidad de Chile, 2016)
La Hipertensión Pulmonar (HP) es una patología vascular compleja que conduce a falla cardíaca, menor expectativa de vida y tiene un impacto significativo en la sociedad, ya que produce la muerte de pacientes en edad ...